Company intelligence / Profile preview

Solarvest BioEnergy

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Organic, algae-derived, vegan, non-GMO FDA-approved DHA/EPA Omega-3 supplement commercially launched; BMP and cannabinoid programs in development; company halted operations April 2023 due to lack of funding, R&D/Manufacturing facility up for sale in 2024.

Therapeutic areas: OtherMetabolic Disorders
Modalities: BiologicRecombinant proteinAlgae-derived products
Industry: Biotech

Partnerships

Eversea (own consumer brand, distributed via strategic partnerships, including white label)Contract manufacturers (not named)

Beyond the preview

Go deeper on Solarvest BioEnergy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solarvest BioEnergy.

Explore the full profile